Correlation Between FrontView REIT, and Guangzhou Baiyunshan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Guangzhou Baiyunshan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Guangzhou Baiyunshan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FrontView REIT, and Guangzhou Baiyunshan Pharmaceutical, you can compare the effects of market volatilities on FrontView REIT, and Guangzhou Baiyunshan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Guangzhou Baiyunshan. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Guangzhou Baiyunshan.

Diversification Opportunities for FrontView REIT, and Guangzhou Baiyunshan

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between FrontView and Guangzhou is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Guangzhou Baiyunshan Pharmaceu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guangzhou Baiyunshan and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Guangzhou Baiyunshan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guangzhou Baiyunshan has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Guangzhou Baiyunshan go up and down completely randomly.

Pair Corralation between FrontView REIT, and Guangzhou Baiyunshan

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the Guangzhou Baiyunshan. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 2.49 times less risky than Guangzhou Baiyunshan. The stock trades about -0.04 of its potential returns per unit of risk. The Guangzhou Baiyunshan Pharmaceutical is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  130.00  in Guangzhou Baiyunshan Pharmaceutical on September 24, 2024 and sell it today you would earn a total of  84.00  from holding Guangzhou Baiyunshan Pharmaceutical or generate 64.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy23.32%
ValuesDaily Returns

FrontView REIT,  vs.  Guangzhou Baiyunshan Pharmaceu

 Performance 
       Timeline  
FrontView REIT, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.
Guangzhou Baiyunshan 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Guangzhou Baiyunshan Pharmaceutical are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Guangzhou Baiyunshan reported solid returns over the last few months and may actually be approaching a breakup point.

FrontView REIT, and Guangzhou Baiyunshan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FrontView REIT, and Guangzhou Baiyunshan

The main advantage of trading using opposite FrontView REIT, and Guangzhou Baiyunshan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Guangzhou Baiyunshan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guangzhou Baiyunshan will offset losses from the drop in Guangzhou Baiyunshan's long position.
The idea behind FrontView REIT, and Guangzhou Baiyunshan Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets